Hapoalim goes global

The foreign currency mortgage program is part of an overall effort by Bank Hapoalim to encourage foreign real estate investments, specifically from Europe and the United States.

By YONI TEITZ
July 3, 2007 08:24

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

In anticipation of foreign investments in Israeli real estate, Bank Hapoalim announced Monday that it would offer mortgages in foreign currencies for its customers. Customers can pay the mortgage in either Euros or dollars, and collect any returns in the same currency. The foreign currency mortgage program is part of an overall effort by Bank Hapoalim to encourage foreign real estate investments, specifically from Europe and the United States. Bank Hapoalim will also add mortgage advisers fluent in foreign languages, and provide mortgage contracts in English and French.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS